✦ LIBER ✦

Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes

✍ Scribed by P.M. WOJNAROWICZ; A. BREZNAN; S.L. ARCAND; A. FILALI-MOUHIM; D.M. PROVENCHER; A.-M. MES-MASSON; P.N. TONIN

Book ID: 109086338
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 709 KB
Volume: 18
Category: Article
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2007.01134.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transcriptome analysis of serous ovarian

Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes

✍ Ashley H. Birch; Michael C.J. Quinn; Ali Filali-Mouhim; Diane M. Provencher; Ann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

## Abstract Cytogenetic, molecular genetic and functional analyses have implicated chromosome 3 genes in epithelial ovarian cancers (EOC). To further characterize their contribution to EOC, the Affymetrix U133A GeneChip® was used to perform transcriptome analyses of chromosome 3 genes in primary cu

Patterns of expression of chromosome 17

Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines

✍ Presneau, Nadège; Mes-Masson, Anne-Marie; Ge, Bing; Provencher, Diane; Hudson, T 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 655 KB

Analysis of gene expression identifies P

Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells

✍ Appierto, V; Villani, M G; Cavadini, E; Gariboldi, M; De Cecco, L; Pierotti, M A 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 338 KB

Reduced expression of MYO18B, a candidat

Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer

✍ Nozomu Yanaihara; Michiho Nishioka; Takashi Kohno; Ayaka Otsuka; Aikou Okamoto; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 399 KB 👁 2 views

## Abstract Allelic imbalance on chromosome arm 22q has been detected in 50–70% of ovarian cancers, suggesting the presence of a tumor‐suppressor gene on this chromosome arm that is involved in ovarian carcinogenesis. Recently, we isolated a candidate tumor‐suppressor gene, __MYO18B__, at 22q12.1,

cAMP induced modifications of HOX D gene

cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers

✍ M. Cantile; A. Kisslinger; L. Cindolo; G. Schiavo; V. D'antò; R. Franco; V. Alti 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB

The acquisition of epithelial-neuroendocrine differentiation (ND) is a peculiarity of human advanced, androgen-independent, prostate cancers. The HOX genes are a network of transcription factors controlling embryonal development and playing an important role in crucial adult eukaryotic cell function

Induction of human tumor-associated diff

Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1–positive healthy donors and patients with advanced ovarian cancer

✍ Stefania Bellone; Simone Anfossi; Timothy J. O'Brien; Martin J. Cannon; Dan-Arin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 583 KB

## Abstract ## BACKGROUND: Tumor‐associated differentially expressed gene‐12 (TADG‐12) is a serine protease recently found highly differentially expressed in epithelial ovarian cancer. The goal of this study was to identify potential immunogenic peptides derived from TADG‐12 for immunotherapy of o